Phospholipase C inhibitor U73122 attenuates the dipsogenic response induced by angiotensin Ii
Brown, T.E.; Wright, J.W.; Speth, R.C.
Proceedings of the Western Pharmacology Society 46: 61-63
2003
ISSN/ISBN: 0083-8969 PMID: 14699887 Document Number: 553476
Document emailed within 1 workday
Related Documents
Kawahara, Y.; Kariya, K.; Araki, S.; Fukuzaki, H.; Takai, Y. 1988: Platelet-derived growth factor (PDGF)-induced phospholipase C-mediated hydrolysis of phosphoinositides in vascular smooth muscle cells--different sensitivity of PDGF- and angiotensin II-induced phospholipase C reactions to protein kinase C-activating phorbol esters Biochemical and Biophysical Research Communications 156(2): 846-854Luo, X.-j.; Ji, S.-k.; Liu, B.; Zhang, H.-f.; Yang, Z.-b.; Ma, Q.-l. 2012: NADPH oxidase inhibitor apocynin attenuates ischemia/reperfusion induced myocardial injury in rats Zhonghua Xin Xue Guan Bing Za Zhi 40(12): 991-996
Pencheva, T.; Gindeva, R.; Strashimirov, D. 1987: Dipsogenic and pressor responses after intraventricular administration of angiotensin II in rats treated neonatally with the hormone Eksperimentalna Meditsina i Morfologiia 26(4): 14-18
Kawata, T.; Hashimoto, S.; Koike, T. 1996: The angiotensin receptor antagonist 2-ethoxy-1-[[2'-(1H- tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV11974) attenuates the tubuloglomerular feedback response during NO synthase blockade in rats Journal of Pharmacology and Experimental Therapeutics 277(2): 572-577
Murakami, K.; Okajima, K.; Uchiba, M.; Okabe, H.; Takatsuki, K. 1996: Gabexate mesilate, a synthetic protease inhibitor, attenuates endotoxin-induced pulmonary vascular injury by inhibiting tumor necrosis factor production by monocytes Critical Care Medicine 24(6): 1047-1053
Buranakitjaroen, P.; Sriussadaporn, S.; Phoojaroenchanachai, M.; Sangprasert, P.; Saravich, S. 2003: Angiotensin converting enzyme inhibitor induced cough: experience in Siriraj Hospital Journal of the Medical Association of Thailand 86(7): 647-654
Tada, H.; Egashira, K.; Yamamoto, M.; Ueno, H.; Takemoto, M.; Shimokawa, H.; Takeshita, A. 1997: Glibenclamide, a specific inhibitor of ATP-sensitive K+ channels, inhibits coronary vasodilation induced by angiotensin II-receptor antagonists Journal of Cardiovascular Pharmacology 30(3): 313-319
Gilchrist, N.L.; Richards, A.M.; March, R.; Nicholls, M.G. 1989: Effect of sulindac on angiotensin converting enzyme inhibitor-induced cough: randomised placebo-controlled double-blind cross-over study Journal of Human Hypertension 3(6): 451-455
Purdy, R.E.; Weber, M.A.; Prins, B.A.; Stupecky, G.L. 1987: Angiotensin Ii induced amplification of the vasoconstrictor response to norepinephrine and clonidine Proceedings of the Western Pharmacology Society 30: 171-174
Lindgren, B.R.; Grundström, N.; Andersson, R.G. 1988: Effects of an alpha-2 adrenoceptor agonist on angiotensin converting enzyme inhibitor-induced hypotension and potentiated allergen-evoked inflammatory skin responses Journal of Pharmacology and Experimental Therapeutics 245(3): 932-935
Anantharaman, R.; Bhansali, A.; Bhadada, S.K.; Kohli, H.S.; Dutta, P.; Walia, R.; Jayaprakash, P.; Upreti, V. 2010: Anti-albuminuric efficacy of a combination of angiotensin converting enzyme inhibitor and angiotensin receptor blocker in type 1 DM with nephropathy Indian Journal of Medical Research 132: 42-47
Iimura, O.; Kusano, E.; Tanba, K.; Yanagiba, S.; Amemiya, M.; Ando, Y.; Honma, S.; Muto, S.; Asano, Y. 2003: Additive antiproteinuric effect of angiotensin Ii receptor antagonist and angiotensin-converting enzyme inhibitor in patients with chronic glomerulonephritis Nihon Jinzo Gakkai Shi 45(5): 439-444
Kono, T.; Ikeda, F.; Oseko, F.; Imura, H.; Endo, J. 1978: Angiotensin i converting enzyme inhibitor and angiotensin Ii antagonist Nihon Rinsho. Japanese Journal of Clinical Medicine 36(11): 3613-3620
Diskin, C.J.; Stokes, T.J.; Dansby, L.M.; Radcliff, L.; Carter, T.B. 2007: Will the addition of pentoxifylline reduce proteinuria in patients with diabetic glomerulosclerosis refractory to maximal doses of both an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker? Journal of Nephrology 20(4): 410-416
Zhang, R.-y.; Huang, Y.-l.; Sun, Y.-h. 2005: Effects of combination therapy with angiotensin I-converting enzyme inhibitor and angiotensin 1 receptor antagonist on ventricular remodeling and expression of endothelial nitric oxide synthase Zhonghua Yi Xue Za Zhi 85(15): 1053-1056
Antelava, N.A.; Gongadze, N.V.; Gogolauri, M.I.; Kezeli, T.D.; Pachkoriia, K.Z. 2007: Comparative characteristic of angiotensin-converting enzyme inhibitor--captopril and the angiotensin Ii receptor blokers--losartan action on the oxidative metabolism in experimental hyperlipidemia in rabbits Georgian Medical News 150: 57-60
Bartuś, J.B.; Chłopicki, S. 2003: Effect of neutral endopeptidase inhibition on vascular response induced by exogenous angiotensin i in the isolated rat lung Polish Journal of Pharmacology 55(6): 1071-1078
Kamiya, H.; Okumura, K.; Ito, M.; Saburi, Y.; Tomida, T.; Hayashi, K.; Matsui, H.; Hayakawa, T. 2001: Calcineurin inhibitor attenuates cardiac hypertrophy due to energy metabolic disorder Canadian Journal of Cardiology 17(12): 1292-1298
Philips, J.C.; Weekers, L.; Scheen, A.J. 2001: Clinical study of the month. The CALM study assessing the combination of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist in the treatment of diabetic nephropathy Revue Medicale de Liege 56(2): 126-128
Trapani, A.J.; De Lombaert, S.; Kuzmich, S.; Jeng, A.Y. 1995: Inhibition of big ET-1-induced pressor response by an orally active dual inhibitor of endothelin-converting enzyme and neutral endopeptidase 24.11 Journal of Cardiovascular Pharmacology 26(Suppl): S69-S71